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ABSTRACT 
 
We investigated Ureaplasma urealyticum genital tract colonisation rates in an 
Australian population to determine whether colonisation was associated with adverse 
pregnancy outcome.  Women attending an antenatal clinic were evaluated for lower 
genital tract colonisation at their first antenatal visit (162 women) and at 28 weeks 
gestation (120 women).  Placentas from 92 women were cultured.  U.  urealyticum 
was the predominant isolate from the lower (57.4%) and upper (17.4%) genital tract 
in this population of pregnant women.  U.  urealyticum was a  persistent coloniser 
during mid-trimester of pregnancy (in 88% of women colonised) whereas M.  
hominis, G.  vaginalis, and Group B  streptococcus were present as transient flora of 
the lower genital tract.  Lower genital tract colonisation during pregnancy was not 
directly associated with adverse pregnancy outcome.  However preterm delivery in 
afebrile, asymptomatic women, could possibly be associated with chorioamnionitis  
(four of 16 preterm births).  Screening of women with a history of preterm birth may 
prevent upper genital tract infections and preterm delivery. 
INTRODUCTION 
 
 
Ureaplasma urealyticum is the potentially pathogenic microorganism most frequently 
isolated from the lower and upper genital tract of women (1,2).  However its role in  
invasive infections remains controversial.  Many studies have shown that lower 
genital tract colonisation with U.  urealyticum is not directly correlated with adverse 
pregnancy outcome.  In a multicentre study by Carey et al  (1), 4,934 women were 
evaluated for vaginal colonisation between 23-26 weeks, and U.  urealyticum was 
found not to be directly associated with preterm rupture of membranes, preterm 
labour or preterm birth. Similarly cervical infections in 1,365 women at their first 
antenatal visit did not predict low birth-weight, abortion, stillbirth, preterm birth and 
preterm prolonged rupture of membranes (3).   Whilst McGregor et al (4) found that 
women with bacterial vaginosis had an increased risk of preterm labour, and 
Mycoplasma  hominis was also shown to be associated with preterm labour and 
preterm birth, their data did not demonstrate a relationship between U.  urealyticum 
colonisation and adverse pregnancy outcome.  Polk et al  (5) showed an association 
between preterm birth and Chlamydia trachomatis and M.  hominis colonisation; 
however, again there was no association with U.  urealyticum.  Others however have 
demonstrated a link between U.  urealyticum and preterm birth and preterm labour 
(6,7).  U.  urealyticum and other organisms found in bacterial vaginosis have been 
shown to be associated with an increased risk of preterm labour (6). In an Australian 
population of 786 women, McDonald et al  (7) found  that women carrying 
Gardnerella  vaginalis (16%) or U.  urealyticum (34%) during their mid-trimester had 
nearly twice the risk of preterm birth; however, in this study tests were not performed 
for C. trachomatis.  
 
U.  urealyticum is a significant cause of chorioamnionitis frequently with the sequelae 
of adverse pregnancy outcome and perinatal morbidity and mortality (2,8).  U.  
urealyticum is the organism predominantly isolated from newborns with chronic lung 
disease (9) and meningitis (in some populations) (10).  Only a small proportion of 
women colonised with U.  urealyticum in the lower genital tract develop 
chorioamnionitis.  It remains to be determined if upper genital tract infection is due to 
maternal factors, infections ascending from the lower genital tract, the individual 
pathogenicity of the ureaplasma isolates, or a combination of these factors. 
 
This present study was conducted to:  (i) establish the U.  urealyticum colonisation 
rates and the duration of lower genital tract colonisation during pregnancy in an 
Australian population (ii) determine the demographic and behavioural characteristics 
associated with U.  urealyticum colonisation (iii) determine if either lower or upper 
genital tract colonisation with U.  urealyticum was  associated with adverse 
pregnancy outcome (iv) identify factors associated with preterm delivery. 
  
MATERIALS AND METHODS 
 
Population 
 
From August to December, 1993, 162 women attending the Toowoomba Base 
Hospital local public antenatal clinic for their first antenatal visit (8-25 weeks) were 
enrolled in this prospective study.  Informed consent was obtained from all 
participants and the study was approved by the Ethics Committees of the University 
of Southern Queensland and the Darling Downs Regional Health Authority.  Upon 
enrolment participants were interviewed and completed a standard questionnaire in 
order to provide demographic and behavioural information and a medical history of 
previous deliveries and of past genital tract infections.   
 
Microbiology 
 
Specimen collection 
 
A speculum examination  was performed at the first antenatal visit (8-25 weeks) and 
separate endocervical samples were collected  for:  Papanicolaou  smear;  
Chlamydia EIA test, Vidas Tm (Vitek/bioMerieux, Hazelwood, MO) (swab placed in 
transport media);  Ureaplasma/Mycoplasma culture;  bacteriological screen (swab 
placed in charcoal transport media); and a smear for Gram staining.  A further 
specimen was collected from the posterior fornix of the high vagina for 
Ureaplasma/Mycoplasma culture.  The Ureaplasma swabs were: (i) inoculated 
immediately onto Mycoplasma A8 agar medium (modified) (Becton Dickinson, 
Brisbane, Australia) and (ii) also vortexed and expressed into Shepard U9B liquid 
broth (11) (then held at 40 C until transported to the laboratory).  After each clinic, 
specimens were transferred  to the laboratory and processed immediately.  
Specimens were also collected at 28 weeks’ gestation.  Endocervical specimens and 
a vaginal specimen were collected by speculum examination for a bacteriological 
screen and for Ureaplasma/Mycoplasma culture.  In addition a low vaginal swab and 
a rectal swab were collected for isolation of Group B Streptococcus. 
 
U.  urealyticum and M.  hominis isolation 
 
A8 agar plates were incubated at 370C, under 95% N2 and 5% CO2 atmosphere. 
Plates were examined microscopically  after 2 days and ureaplasma and/or 
mycoplasma colonies were excised on an agar block, subcultured in U9B broth and 
stored at -700C for future testing.  Four serial 10-fold dilutions  were made of the 
U9B broth culture and 2 aliquots (0.5 mL) of the remaining original specimen were 
frozen at -700C.  Ureaplasma growth was detected and quantitated by an alkaline 
shift and subsequent colour change in  
the media.  Broths were subcultured onto A8 agar and into a further U9B broth just 
as the pH change began.  Broths showing no colour change were routinely 
subcultured onto A8 agar after 2 days. 
 
Chlamydia trachomatis detection 
 
All samples were tested using the Chlamydia EIA, VIDAS Tm  (Vitek/bioMerieux, 
Hazelwood, MO).  Positive results were confirmed by DFA (Cellab). 
 
Bacteriology 
 
All swabs from charcoal transport medium were inoculated routinely onto Horse 
Blood agar, MacConkey agar (BBL, Cockeysville, Md), Sabouraud dextrose agar 
with chloromycetin, and half Chocolate Agar/ New York plate (Oxoid, Australia) for  
the isolation of bacterial and yeast pathogens.  A wet preparation in saline was 
examined for the presence of motile trichomonads and the swab was then incubated 
in a thioglycollate broth for the detection of anaerobic bacteria. All plates were 
incubated at 370C under 5% CO2 atmosphere.  Twenty eight-week low vaginal and 
rectal swabs were inoculated onto Streptococcus selective media (Oxoid, Australia) 
and Horse Blood agar.  The Gram stains were examined for the presence of G.  
vaginalis and Mobiluncus species morphotypes and other bacteria and yeasts, the 
presence of 'clue' cells and for the quantitation of leucocytes. Slides were evaluated 
by two independent readers who were unaware of culture results.  
 
Placenta culture and histology 
 
After delivery, placentas from 93 participants were available for culture and 
histological examination. The chorionic surface of the placenta was sterilised by 
burning alcohol (2).  Using aseptic technique, a block of villous tissue was excised, 
inoculated onto an A8 agar plate, a Horse Blood agar plate, and a  half Chocolate 
Agar/ New York plate (Oxoid, Australia) and then placed into U9B broth.  Three 
serial  10-fold dilutions were made of the U9B broth.  Broths were subcultured at the 
beginning of the pH change or after 2 days incubation.   The placenta was then fixed 
for histological examination.  Histological examination of the placenta was performed 
in eight of 16 preterm births and 8 of 129 (placenta culture positive) term births.  The 
placenta was sliced and macroscopically abnormal areas were sectioned for 
histological examination of both the maternal and foetal surface. Macroscopically 
abnormal areas of the cord and membranes were also sectioned.  Chorioamnionitis 
was diagnosed by the presence of an acute inflammatory cell response in the 
membranes. 
 
 
 
 
 
Statistical methods 
 
The data involved in this prospective study involved mainly tests of equality of 
proportions.  These were performed using the chi-squared test or Fisher exact test 
as appropriate. 
 
RESULTS 
Population 
 
The majority of the participants were Caucasian 136 (84%), 17 were Aboriginals 
(10.5%) and seven were of Asian descent (4.3%). The mean maternal age was 24.9 
 5.2, years with a  range from 15 to 42 years. The mean gestational age at 
enrolment was 14.9  3.6 weeks.  The mean parity was 2.4  1.6. 
 
Lower genital tract flora 
 
Table 1 shows the recovery rates of microorganisms from lower genital tract 
specimens collected from 162 women during the first antenatal visit and from 120 
women who were retested at 28 weeks’ gestation.   
 
 
TABLE 1.  ‘Microbiological screen' of pregnant women 
   
 1st visit 
(14.9  3.6  weeks) 
28 weeks 
Microorganism 
 
 
Carriage 
(n=162) 
n (%) 
Carriage 
(n=120) 
n (%) 
 
Ureaplasma                    endocervix 
urealyticum                            vagina 
(UU)                                       either 
70 (43.2)  
90 (55.6)     
93 (57.4)    
60 (50) 
62 (51.7) 
63 (52.5) 
Mycoplasma hominis      endocervix 
(MH)1                                     vagina 
                                                either 
9 (5.6)  
11 (6.7)    
12 (7.4)     
5 (4.1) 
4 (3.3) 
6 (5) 
Gardnerella vaginalis,     endocervix  
(GV) 
8 (4.9)   5 (4.2) 
Group B Streptococci     
(GBS) 
4 (2.5) endocervix 
 
20 (16.7)low vaginal, rectal 
5 (4.1)    endocervix 
Chlamydia trachomatis (CT) 6 (3.7) NT  
Candida albicans 8 (4.9) 10 (8.3) 
Trichomonas vaginalis 1 (0.6) NT 
GV + UU 4 (2.5) 3 (2.5) 
GV + UU + MH 1 (0.6) 1 (0.8) 
GBS + UU 2 (1.2) 7 (5.8)  
CT + UU 4 (2.5) - 
CT + UU + MH 1 (0.6) - 
GV + CT + UU 1 (0.6) - 
GBS + GV - 1 (0.8) 
 
1=always found in association with U.  urealyticum, NT=not tested 
Of the organisms investigated in this study U. urealyticum was the most prevalent 
coloniser of the lower genital tract in the second (57%) and third trimester (53%) of 
pregnancy.  Overall 5.6% of women were colonised with M.  hominis and this is a 
much lower colonisation rate than reported in overseas studies (24 - 39.9%) (4-6). 
Isolation rates for G.  vaginalis (4.6%) and C.  trachomatis (3.7%) were also very 
low, although a more recent study of C.  trachomatis detection in our population has 
shown a low sensitivity of VIDAS Tm EIA, compared to PCR when testing 
asymptomatic carriers (12).   Polymicrobial colonisation was present in 26 women 
(16%).  As shown in Table 2, in this Australian population U.  urealyticum was 
isolated more frequently (p=0.03) from Aboriginal women (82%) than from 
Caucasian (59%) or Asian women (28%).   There was a higher U.  urealyticum 
colonisation rate in smokers (67.2%, p=0.03) and in women who had previously used 
non-barrier contraceptives (57.9%, p=0.03).  U. urealyticum colonisation was 
significantly associated with several 'risk' factors: (i) single marital status (p<0.01); (ii) 
more than 1 sexual partner in the previous 12 months (p=0.01); and (iii) 
commencement of sexual activity at less than 18 years of age (p<0.01).  There were 
no significant associations between U.  urealyticum and either C. trachomatis, or G.  
vaginalis, or  M.  hominis or  Group B streptococcus. 
 
 
TABLE 2.  Demographic and behavioural characteristics of women colonised with U.  
urealyticum (UU) in the lower genital tract 
 
  Endocervical 
Samples 
 High 
Vaginal 
Samples 
 
Characteristic Number 
of 
women 
% UU  
culture 
positive 
 
p value 
 
% UU  
culture 
positive 
 
p value 
 
 
Race-Aboriginal 
        -Caucasian 
        -Asian 
   17 
136 
     7 
64.7 
58.8 
14 
0.05 82.4 
55.1 
28.6 
0.03 
Single 
Married 
   77 
   85 
55.84 
30.5 
0.001 75 
40 
.0001 
 
1 sexual partner in past year 
>1 sexual partner in past year 
146 
   12 
41.1 
66.7 
0.08 53.4 
91.7 
0.01 
 
Began sexual activity age 18 
Began sexual activity age >18 
127 
  30 
48.8 
16.7 
0.001 60.6 
40.0 
0.04 
 
Non-barrier contraception 
Barrier contraception 
133 
  19 
43.6 
26.3 
0.15 57.9 
31.6 
0.03 
Education    <Grade 12 
             Completed Grade 12 
              Tertiary 
  96 
  33 
  33 
46.8 
50 
65 
0.07 61.5 
51.5 
48 
0.04 
Alcohol consumption- Yes 
                                   - No 
  23 
138 
43.5 
42.8 
0.94 52.2 
57.3 
0.64 
Marijuana use            - Yes 
                                   - No 
    5 
156 
60 
42.3 
0.43 80 
55.8 
0.28 
Smoking                     - Yes 
                                   - No 
  61 
100 
50.8 
38 
0.11 67.2 
50 
0.03 
 
Not all of the 162 women were retested at 28 weeks.  These defaulters either (i) 
elected not to have further lower genital tract specimens collected, (ii) failed to attend 
the antenatal clinic or (iii) clinicians advised against collection of specimens when 
other obstetric maternal risk factors were present.   
 
Significantly this  study documents the duration of  lower genital tract colonisation in 
pregnancy (Table 3).  Of those women colonised with U.  urealyticum , 88% (59/67) 
were colonised at the first antenatal visit and also at 28 weeks.  Whilst the isolation 
rates of M.  hominis, G.  vaginalis were very low, it appears  that these organisms 
and Group B streptococcus were  present in the lower genital tract as transient flora.  
The higher total incidence of Group B streptococcus at 28 weeks is due to the 
additional, routine collection of specimens from the low vagina and rectum at that 
time.  All women who tested positive for C.  trachomatis at their first antenatal visit 
were treated. Two of these women were positive for both C.  trachomatis and U.  
urealyticum and were treated with erythromycin until tests for C.  trachomatis were 
negative.   U.  urealyticum was detected in both these women again at 28 weeks. 
 
 
 
TABLE 3. Duration of colonisation of the lower genital tract 
 
Colonising 
microorganism 
Total 
number of  
women 
colonised 
(n=120) 
Colonised at 
1st antenatal 
visit only 
 
(n) 
Colonised 
at 28 weeks 
only 
 
(n) 
Colonised at 
both 1st visit 
and 28 weeks 
 
n (%) 
 
U.  urealyticum 67 4 4 59 (88) 
M.  hominis 8 2 3 3 (37.5) 
G.  vaginalis 10 5 5 0 
Group B 
streptococcus 
19  (total) 
5  (endocervix) 
0 
0 
16 
3 
3 (15.8) 
2 (40) 
 
 
 
Pregnancy outcome 
 
There were 16 (11%) preterm deliveries (<37 weeks), one miscarriage, one blighted 
ovum, one intrauterine foetal death at 15 weeks’ gestation and 129 (87%) term 
deliveries.  Delivery details were not obtainable for 14 participants.  Twenty three 
(15.9%) women experienced preterm labour and five (3.4%) women had preterm 
rupture of membranes.  Twelve (8.3%) low birth-weight infants (<2,500g) and two 
(1.3%) very low birth-weight infants (<1,500g) were delivered.  A comparison of the 
rates of colonisation of U.  urealyticum in women who delivered at term and those 
who delivered preterm (Table 4) demonstrated no significant difference in the 
colonisation rates.  However it is unusual that the colonisation rates of U.  
urealyticum were lower in those women who delivered  preterm (42.5%), compared 
to those who delivered at term (52.5%).  The presence of U.  urealyticum in the 
endocervix or the vagina was not significantly associated with adverse pregnancy 
outcome.  The isolation of C.  trachomatis,  G.  vaginalis,  M.  hominis,  and Group B 
streptococcus from the lower genital tract was also not significantly associated with 
preterm delivery.  
 
 
TABLE 4. Lower genital tract colonisation with U.  urealyticum at the first 
antenatal visit (12-20 weeks) and at 28 weeks-a comparison of women who 
delivered preterm and those who delivered at term 
 
Time of antenatal 
visit 
Preterm deliveries 
% endocervix / % vagina 
colonisation 
Term deliveries 
% endocervix / % vagina 
colonisation 
 
1st antenatal visit1 
( 14.9 3.6 weeks) 
 
37.5 / 43.8 42.6 / 59.7 
28 weeks 2 
 
44.4 / 44.4 51.9 / 55.8 
1 n=145,  
2
 n=113 
 
 
Placenta culture and histology 
 
Of the preterm placentas 44% (4 of 9) were 'culture positive' compared to 18% (15 of 
83) of the term placentas (p=0.07).  U.  urealyticum 16 of 92 (17.4%) and M.  hominis 
4 of 92 (4.3%) were the organisms isolated most frequently from placentas.  Whilst 
not all placentas were examined histologically it is interesting to note that the 
histology results revealed:  (i) evidence of ascending infection in three of eight 
culture positive term placentas (culture negative term placentas were not examined) 
and three of eight preterm placentas; (ii) chorioamnionitis in four women (4 of 8) who 
delivered preterm and one woman who delivered at term (1 of 8 culture positive 
placentas).  Not all preterm placentas were available for culture and histology as 
some women were transferred to a major teaching hospital for delivery.  Due to the 
small numbers these outcomes were not statistically analysed.  
 
Preterm birth 
 
In this population, as would be expected, preterm birth was significantly associated 
with maternal risk factors of:  smoking (p=0.012), cervical incompetence (p<0.0001), 
polyhydramnios (p<0.01), production of anti-Kell antibodies (p<0.01) and in women 
expecting twins (p<0.0001).  A history of prior preterm birth (p<0.0001) and of a 
previous low birth-weight infant (p<0.01) was also more common in those women 
who delivered preterm.  For 10 of 16 women who delivered preterm it was their 
second or subsequent pregnancy. Five of these 10 women had previously delivered 
preterm. Three of the five women (with previous preterm and present preterm 
delivery) were colonised in the lower genital tract with U.  urealyticum.  One other of 
these five women (and her partner) had been treated with tetracycline prior to 
conception until cultures for U.  urealyticum were negative.  
 
Identification of causes of preterm deliveries 
 
Of those women who delivered preterm 11 of 16 (68.8%) had one or more maternal 
obstetric risk factors as compared to 15 of 129 (11.6%) of women who delivered at 
term.  By comparing the lower genital tract microbiological findings and the maternal 
obstetric risk factors of women who delivered preterm (Table 5) it is apparent that 
eight of the 16 preterm deliveries (Preterm Patient Nos 3, 5, 8, 9, 12, 13, 15, 16)  can 
be attributed to maternal risk factors.  In seven of the remaining eight preterm 
deliveries, infectious agents could possibly be a  contributing (causal) factor.  Five of 
the 16 women who delivered preterm were Aboriginal or had Aboriginal partners and 
four of these women were colonised with U.  urealyticum, whilst of the remaining 11 
women only three were colonised with U.  urealyticum (p=0.064).  This result is 
based on a small sample and suggests that further investigation of the relationship 
between race, the incidence of U.  urealyticum colonisation in Aboriginals  and its 
involvement in preterm deliveries is warranted. 
 
Chorioamnionitis was diagnosed histologically in four women: Patient No 2 had 
preterm prolonged rupture of membranes (>1 week) and a positive placenta culture 
for U.  urealyticum, with evidence of ascending infection: Patient No 4 had a positive 
placenta culture for G.  vaginalis  and  U.  urealyticum and Patient No 10 had a 
positive placenta culture for U.  urealyticum.  In these three women U. urealyticum  
was also isolated from the lower genital tract during the pregnancy.  Of interest two 
of these three patients were Aboriginal (Patients No 2 and 4), and two patients had 
Aboriginal partners (Patients No 2 and 10). Preterm Patient No 14 delivered twins at 
23 weeks, and postmortem histology of the infants and placentas reported extreme 
prematurity, acute chorioamnionitis and an ascending infection.  The placenta was 
fixed and microbiological culture of the tissue was not performed.  The pregnancy 
histories for another three women (Patients No 6, 7, 11) suggested that an infectious 
agent may be implicated in the preterm birth.  Therefore of these 16 preterm 
deliveries an infectious agent may be implicated in at least  four (25%).  
 
 
  
DISCUSSION 
 
This study confirms that whilst U.  urealyticum is the most prevalent microorganism 
isolated from the lower and upper genital tracts, its mere presence in the lower 
genital tract during pregnancy is not always associated with adverse pregnancy 
outcome.  However this small sample showed that most women with U.  urealyticum 
culture positive placentas and histological evidence of an upper genital tract 
infection,  delivered preterm.  Colonisation rates and demographic and behavioural 
characteristics of women colonised with U.  urealyticum in this population are similar 
to those reported in overseas studies (1,3,4).  Total rates of colonisation with U.  
urealyticum in this population were higher (57.4%) than those reported in another 
Australian population (34.8%) (7) even though both studies surveyed women 
attending public hospital antenatal clinics.   
 
Microorganisms establish various symbiotic relationships within the lower genital 
tract.   By comparing microbiological findings from lower genital tract samples 
collected at the first antenatal visit and again at 28 weeks we have shown that M.  
hominis, G.  vaginalis, and Group B streptococcus can be considered as transient 
flora of the lower genital tract whereas U.  urealyticum is generally present (88% of 
colonised women) from mid-trimester to early third trimester as a constant or 
persistent coloniser of the lower genital tract.  McDonald et al  (13) showed that G.  
vaginalis, U.  urealyticum  and M.  hominis commonly persisted between mid-
trimester and labour. It is not possible to ascertain whether U.  urealyticum is 
constantly present in the lower genital tract or if it is perhaps repeatedly introduced 
from an endogenous source such as the gastrointestinal tract, or from sexual 
partner(s).  Subtyping of the isolates present in the lower genital tract at the first 
antenatal visit and those present at 28 weeks (in the same women) may further 
elucidate the nature of colonisation. 
 
The relationship between antepartum lower genital tract colonisation and adverse 
pregnancy outcome has previously been studied (1-7),  however the design of these 
studies varies considerably particularly with respect to the types of microorganisms 
isolated and the consideration of maternal risk factors (other than aetiological 
agents) associated with adverse pregnancy outcome.  Conflicting results have been 
obtained and it has not been possible to formulate a demographic and 
microbiological profile of women at risk of an adverse pregnancy outcome.  Our 
results confirm that antepartum lower genital tract cultures for U.  urealyticum, M.  
hominis, G.  vaginalis, C.  trachomatis and Group B streptococcus, in 'isolation' are 
not useful for predicting preterm labour, preterm birth nor low birth-weight infants.  
However U.  urealyticum is the most common, potentially pathogenic coloniser in 
both the lower and upper genital tract of pregnant women.  Whilst colonisation of the 
lower genital tract is not predictive of an adverse pregnancy outcome, in this study 
upper genital tract infections due to U.  urealyticum occurred only in women with 
lower genital tract colonisation.  Moreover, histological examination of both term and 
preterm placentas reported evidence of ascending infection and chorioamnionitis, 
which supports an ascending route of invasive infection. Sampling of the upper 
genital tract of pregnant women is an invasive procedure with inherent risks, and 
therefore further investigations of lower genital tract microorganisms and their ability 
to cause invasive, ascending infections is warranted.   
 
The results of this study strongly suggested that four of 16 preterm births which 
occurred in afebrile, asymptomatic women were as a result of acute chorioamnionitis 
(three of these in the absence of preterm prolonged rupture of membranes).  U.  
urealyticum alone (two cases), and  U.  urealyticum and G.  vaginalis (one case) 
were isolated from these placenta cultures. No culture results were available for the  
fourth case.  Associations of chorioamnionitis and intrauterine infection have 
previously been documented (2,8).  These infections may be asymptomatic (2) and 
so the problem remains in identifying women with intact membranes and 
asymptomatic upper genital tract infections.  It may be as suggested by Cassell et al 
(14) that U.  urealyticum is present in the endometrium at the time of implantation 
and subsequently infects amniotic fluid and the placental membranes resulting 
ultimately in an adverse pregnancy outcome. Alternatively, (i) there may be a sub-
population of women colonised in the lower genital tract who possess maternal risk 
factors which facilitate ascending microorganisms, (ii) some ureaplasmas present in 
the lower genital tract may be more pathogenic than others, and capable of 
ascending and causing upper genital tract infections or (iii) pathogenicity may be due 
to a combination of these factors.  
 
The pathogenicity of the ureaplasmas may be dependent on antigenic variation 
within the species.  Studies have sought to evaluate the pathogenicity of the different 
serovars of U.  urealyticum.  However Zheng et al  (15) concluded that the 
invasiveness was not limited to a few particular serotypes among the 14 serovars of 
U.  urealyticum.  Other methods of subtyping the ureaplasmas have been reported 
and these are also being used to investigate the pathogenicity of different clinical 
isolates (16).  There is still a need to develop alternate molecular subtyping methods 
for ureaplasmas with the ultimate aim of using these methods to identify clinical 
isolates with a greater potential for producing invasive infections.  Meanwhile, 
antepartum lower genital tract microbiological screening of pregnant women in order 
to predict adverse pregnancy outcome is not useful.  By comparison routine culture 
of all amniotic fluids collected by amniocentesis as well as culture and histology of all 
placentas from preterm births may reveal the true incidence of adverse pregnancy 
outcome due to infectious agents.  With thorough microbiological antepartum 
screening of women who have a history of a prior preterm birth and subsequent 
appropriate antibiotic management, it may be possible to prolong the gestation of 
women at risk of preterm delivery or to prevent upper genital tract infections and 
adverse pregnancy outcome. 
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